Literature DB >> 21513441

Physiologic correlates of sleep quality in severe emphysema.

Samuel L Krachman1, Wissam Chatila, Ubaldo J Martin, Irene Permut, Gilbert E D'Alonzo, John P Gaughan, Alice L Sternberg, David Ciccolella, Gerard J Criner.   

Abstract

BACKGROUND: Sleep quality is poor in severe emphysema. We hypothesized that in addition to nocturnal oxygen desaturation, the severity of airflow obstruction and degree of thoracic hyperinflation are responsible.
METHODS: Twenty-five patients (14 males, 64 ± 6 [ ± SD] yrs, BMI 24.7 ± 4.2 kg/m(2)) with severe emphysema (FEV(1) = 28 ± 8% predicted, TLC = 125 ± 14% predicted) were studied. Measurements included spirometry, lung volumes, arterial blood gas, length of the diaphragm's zone of apposition (LZAP) and a polysomnogram.
RESULTS: Total sleep time (TST) was 227 ± 93 minutes with a sleep efficiency (SE) of 56 ± 21%. The mean SaO(2), lowest SaO(2), and% TST with a SaO(2) < 90% were 90 ± 5%, 83 ± 8% and 29 ± 40%, respectively. TST correlated with FEV(1)% (r = 0.5, p = 0.02), FVC% (r = 0.4, p = 0.03) and LZAP (r = 0.5, p = 0.01). SE correlated with FEV(1)% (r = 0.5, p = 0.02) and LZAP (r = 0.5, p = 0.01), but not with FVC% (r = 0.4, p = 0.07). Additionally, TST and SE correlated negatively with residual volume% (r = -0.4, p = 0.046, and r = -0.4, p = 0.03, respectively). There was no correlation between TST and SE and measures of nocturnal oxygenation. Multiple linear regression was used to predict TST, with 50% (r(2) = 0.49) explained by a combination of LZAP (27%), mean SaO(2) (23%), and the lowest SaO(2) (< 1%). To predict SE, 44% (r(2) = 0.43) was explained by a combination of LZAP (29%), mean SaO(2) (14%), and the lowest SaO(2) (1%).
CONCLUSION: Although parameters of respiratory function and mechanics correlate with sleep quality, both nocturnal oxygenation and measurements of respiratory function/mechanics predict sleep quality in severe emphysema.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513441     DOI: 10.3109/15412555.2011.560583

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  7 in total

1.  High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.

Authors:  Xavier Soler; Eduardo Gaio; Frank L Powell; Joe W Ramsdell; Jose S Loredo; Atul Malhotra; Andrew L Ries
Journal:  Ann Am Thorac Soc       Date:  2015-08

2.  Sleep Quality and Nocturnal Symptoms in a Community-Based COPD Cohort.

Authors:  Aditi Shah; Najib Ayas; Wan-Cheng Tan; Atul Malhotra; John Kimoff; Marta Kaminska; Shawn D Aaron; Rachel Jen
Journal:  COPD       Date:  2020-01-10       Impact factor: 2.409

3.  Pulmonary Overlap Syndromes, with a focus on COPD and ILD.

Authors:  Katherine A Dudley; Atul Malhotra; Robert L Owens
Journal:  Sleep Med Clin       Date:  2014-09

4.  Effects of endobronchial coils for endoscopic lung volume reduction on sleep in COPD patients with advanced pulmonary emphysema.

Authors:  Karl-Josef Franke; Ulrike Domanski; Maik Schröder; Georg Nilius
Journal:  Sleep Breath       Date:  2020-08-26       Impact factor: 2.816

5.  Effect of Triple Therapy with Budesonide-Formoterol-Tiotropium Versus Placebo-Tiotropium on Sleep Quality in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Samuel L Krachman; Maria Elena Vega; Daohai Yu; Joseph Demidovich; Harsh Patel; Frederic Jaffe; Xavier Soler; Tahseen Shariff; Gilbert E D'Alonzo; Wissam Chatila; Sheila Weaver; Yasmin Daraz; Sydney Cohen; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

Review 6.  Update on obstructive sleep apnea and its relation to COPD.

Authors:  Brian Mieczkowski; Michael E Ezzie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-08

7.  Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD.

Authors:  Xavier Soler; Shu-Yi Liao; Jose Maria Marin; Geraldo Lorenzi-Filho; Rachel Jen; Pamela DeYoung; Robert L Owens; Andrew L Ries; Atul Malhotra
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.